The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

Isabelle Bos, Stephanie Vos, Rik Vandenberghe, Philip Scheltens, Sebastiaan Engelborghs, Giovanni Frisoni, Jose Molinuevo, Anders Wallin, Alberto Lleo, Julius Popp, Pablo Martinez-Lage, Alison Baird, Richard Dobson, Cristina Legido-Quigley, Kristel Sleegers, Christine Van Broeckhoven, Lars Bertram, Mara ten Kate, Frederik Barkhof, Henrik ZetterbergSimon Lovestone, Johannes Streffer, Pieter Jelle Visser

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number64
Number of pages9
JournalAlzheimer's Research & Therapy
Volume10
DOIs
Publication statusPublished - 6 Jul 2018

Keywords

  • Alzheimer's disease
  • Biomarkers
  • Multimodal
  • Proteomics
  • Genomics
  • Metabolomics
  • Plasma
  • Magnetic resonance imaging
  • DNA
  • Cerebrospinal fluid
  • CEREBROSPINAL-FLUID BIOMARKERS
  • MILD COGNITIVE IMPAIRMENT
  • BLOOD-BASED BIOMARKERS
  • ALZHEIMERS-DISEASE
  • CSF BIOMARKERS
  • DEMENTIA
  • ATROPHY
  • DIAGNOSIS
  • MRI

Cite this